Symbioflor 2: recommendations of the Committee for Medicinal Products for Human Use regarding further use and restrictions of use
2017.07.04
Active substance: escherichia coli
In its review of Symbioflor 2, the European Medicines Agency EMA has concluded that the medicinal product can continue to be used for treatment of irritable bowel syndrome in adults. However, it should no longer be taken to treat so-called functional gastrointestinal disorders.